Avecia Biotechnology recently engaged BioTechLogic to guide the second phase of its electronically integrated QMS system. The move is designed to streamline Avecia’s QMS processes and was in response to anticipation of commercial manufacture. In April 2010 Avecia announced a manufacturing agreement with Pfizer for the commercial supply of the oligonucleotide component of Macugen. Two other clients of Avecia are planning to apply for marketing approval in 2011. Avecia has already validat...